Journal List > Lab Anim Res > v.27(4) > 1053692

Han and Park: High glucose stimulates glutamate uptakes in pancreatic β-cells

Abstract

Pancreatic β-cells are major cells responsible for glucose metabolism in the body. Hyperglycemia is known to be a primary factor in the induction of diabetes mellitus. Glutamate is also an excitatory neurotransmitter in diverse organs. Oxidative stress also plays a pivotal role in the development of diabetes mellitus. However, the effect of hyperglycemia in glutamate uptake in the pancreas is not clear. Furthermore, the relationship between high glucose-induced glutamate uptake and oxidative stress has not been investigated. Therefore, this study was conducted to investigate the effect of high glucose on glutamate uptake in pancreatic β-cells. In the present study, 25 mM glucose stimulated the glutamate uptake in HIT-15 cells of hamster pancreatic β-cells. The treatment of 25 mM glucose and 1 mM glutamate also decreased the cell viability in HIT-15 cells. In addition, the treatment of 25 mM glucose induced an increase of lipid peroxide formation. High glucose-induced increase of LPO formation was prevented by the treatment of antioxidants such as N-acetyl-L-cysteine and quercetin. Furthermore, high glucose-induced stimulation of glutamate uptake and decrease of cell viability were also blocked by the treatment of N-acetyl-L-cysteine and quercetin. In conclusion, high glucose stimulated glutamate uptake via oxidative stress in pancreatic β-cells.

The pancreas is an important organ for regulating glucose metabolism in the body [1]. Glucose transported into β-cells induced by the increase of plasma glucose levels leads to insulin exocytosis, which manipulates the glucose levels [2]. Hyperglycemia has been known to be a primary factor in triggering diabetes in digestive organs [3]. Glutamate is the most important excitatory amino acid in the nervous system [4]. Recently, it has been reported that glutamate regulates the diverse function of digestive organs [5]. Several lines of evidence suggest that glutamate induces metabolic syndrome such as obesity and diabetes-like hyperglycemia [6,7]. Di Cairano et al [8] also reported that the glutamate transporter is expressed in pancreatic β-cells and is responsible for the protection of glutamate-induced β-cell death. These reports suggest that there may be an interaction between hyperglycemia and glutamate in the pancreas, since the pancreas plays a pivotal role in the regulation of glucose metabolism. However, the regulation of glutamate uptake by hyperglycemia in the pancreas has not been elucidated.
Diverse signaling molecules are involved in the onset of diabetes mellitus [9]. Among them, oxidative stress, which is manifested as increased levels of reactive oxygen species (ROS), has been generally reported to be associated with the development of diabetes [10,11]. Several lines of evidence have suggested that N-acetyl-L-cysteine (NAC) and quercetin protects the diabetes-related oxidative stress in the pancreas [12,13]. These reports suggest the possibility that oxidative stress is involved in the high glucose-induced regulation of glutamate uptake. Thus, this study was conducted to investigate the effect of high glucose on glutamate uptake and its relationship with oxidative stress in pancreatic β-cells.

Materials and Methods

Materials

RPMI 1640medium, fetal bovine serum (FBS), penicillin, and streptomycin were obtained from Hyclone (Logan, UT, USA). HIT-T15 cells were obtained from the American-Type Culture Collection (ATCC, Manassas, VA, USA). D-Glucose was obtained from Sigma (St. Louis, MO, USA). [3H]-L-glutamate was purchased from Dupont/NEN (Boston, MA, USA). All reagents were of the highest purity commercially available.

Cell cultures

We used HIT-T15 cells as a model to study pancreatic β-cells. HIT-T15 cells were cultured in RPMI 1640 medium containing 10% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37℃ in 5% CO2. Cells (1×104 cells/well) were seeded in a 96-well plate and pre-incubated with the same media in a serum-free condition for 24 h.

Cell viability assay

Cell viability was evaluated by the colorimetric MTT assay, using the CellTiter 96® AQueous One solution according to the manufacturer's instructions. Briey, cells (1×106 cells/well) were seeded in a 96-well plate with RPMI 1640 medium containing 10% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin at 37℃ in 5% CO2. Then, the cells were pre-incubated with the same media in a serum-free condition (without FBS) for 24 h and were treated with 25 mM glucose in each experimental condition.

D-[2,3-3H]- Aspartate uptake

The D-[2,3-3H]-aspartate uptake experiments were carried out using a modification of the method described by Wu et al [14]. To study the D-[2,3-3H]-aspartate uptake, the culture medium was removed by aspiration, and the cells were gently washed twice with an uptake buffer (140 mM NaCl, 2 mM KCl, 1 mM KH2PO4, 10 mM MgCl2, 1 mM CaCl2, 5 mM glucose, 5 mM L-alanine, 5 µM indomethacin, and 10 mM HEPES/Tris, pH7.4). After washing, the cells were incubated in an uptake buffer containing 1 µCi/mL D-[2,3-3H]-aspartate at 37℃ for 1 h in 5% CO2 in a humidified cell culture incubator. At the end of the incubation period, the cells were washed three times with an ice-cold uptake buffer and then dissolved in 1 mL 0.1% sodium dodecyl sulfate (SDS). The level of D-[2,3-3H]-aspartate uptake incorporated intracellularly was determined by removing 900 µL of each sample and measuring the radioactivity in a LS 6500 liquid scintillation counter (Beckman Instruments, Fullerton, CA, USA). The remainder of each sample was used to determine the protein level by the method of Bradford [15]. The radioactivity counts in each sample were then normalized with respect to the protein and corrected for zero-time uptake per mg of protein. All the uptake measurements were carried out in triplicate.

Measurement of lipid peroxides

The levels of lipid peroxides (LPO) in the monolayer cells were determined by measuring the malondealdehyde content according to the method of Ohkawa et al [16]. ARPE-19 cells were exposed to 25 mM glucose for 24 h. After exposure terminated, the cells were harvested and sonicated. 100 µL of sonicated cells was mixed with 8% sodium dodecyl sulfate (100 µL), 0.8% 2-thiobarbituric acid (TBA, 200 µL) and 20% acetic acid (200 µL). The mixture was heated to 95 for 60 min. After reaction time, this mixture was cooled in ice-cold water. To extract the nonspecific red pigment, n-butanol-pyridine mixture (15:1 v/v, 1 mL) was added, and the mixture was shaken vigorously, and was then centrifuged at 4,000 rpm for 10 min. The upper organic layer was measured by spectrofluorometry at an emission wavelength of 553 nm with an excitation wavelength of 515 nm. 1,1,3,3-Tetraethoxy-propane was used as a standard and the values of LPO for samples were expressed as nmol/mg protein.

Statistical analysis

The results were expressed as the mean±SE. All the experiments were analyzed by analysis of variance (ANOVA). In some experiments, a comparison of the treatment means was made with the control using the Bonnferroni-Dunn test. A P value <0.05 was considered significant.

Results

Dose-dependent effect of high glucose on glutamate uptake

To examine the dose-dependent effect of high glucose on glutamate uptake, the HIT-15 cells were treated with different dosages of glucose (10, 25,or 50 mM), 25 mM mannitol, or 25 mM L-glucose. As shown in Figure 1A, 25 mM and 50 mM glucose, but not 10 mM glucose, significantly stimulated D-[2,3-3H]-aspartate uptake. However, treatment with 25 mM mannitol or L-glucose did not further change D-[2,3-3H]-aspartate uptake, suggesting that the uptake was glucose specific (Figure 1B). In addition, we examined the time dependent effect of glucose. Thus, HIT-15 cells were exposed to 25 mM glucose for 0-480 min. As shown in Figure 1B, 25 mM glucose significantly stimulated D-[2,3-3H]-aspartate uptake for over 30 min, with a maximum effect at 480 min after high glucose treatment. Thus, 25 mM glucose for 8 h was used in subsequent experiments. Furthermore, we examined high glucose and glutamate induced cell death in HIT-15 cells. Figure 2 demonstrates that high glucose (25 mM and 50 mM glucose), but not 25 mM mannitol, induced the decrease of cell viability. Similarly, the treatment of 1 mM glutamate also decreased the cell viability.

The involvement of oxidative stress in high glucose-induced stimulation of glutamate uptake and cell viability

The relationship between oxidative stress and high glucose-induced stimulation in glutamate uptake was examined. NAC (1 mM) and quercetin (100 µM) antioxidants were used to treat the HIT-15 cells prior to incubation with 25 mM glucose. As shown in Figure 3A, 25 mM glucose induced the increase of LPO formation. NAC and quercetin both blocked high glucose-induced LPO formation. Figure 3B also demonstrated that NAC and quercetin blocked the high glucose-induced stimulation of glutamate uptake. NAC and quercetin prevented the high glucose-induced decrease of cell viability (Figure 4). These results suggest that oxidative stress is involved in the high glucose-induced stimulation of glutamate uptake and the decrease of cell viability.

Discussion

This study firstly demonstrated that high glucose stimulated the glutamate uptake in hamster pancreatic β-cells. Until now, the regulation of glutamate was restricted to the nervous system. However, several lines of evidence have suggested that the metabolism of glutamate is important in the function of non-neural tissues [17-19]. In the present study, high glucose stimulated the glutamate uptake in pancreatic β-cells. These stimulatory effects are D-glucose-specific and are unlikely due to an osmotic effect since the responses were not mimicked by mannitol or L-glucose. To our knowledge, this is the first report in which hyperglycemia stimulated the glutamate uptake in pancreatic β-cells. In pancreatic β-cells, glial glutamate transporter 1 and the vesicle glutamate transporter are expressed [20,21]. In the present study, we did not examine the isoforms of the glutamate transporters. This remains to be studied. Our result also demonstrated that high glucose and glutamate induced the decrease of cell viability. Our result is inconsistent with several reports. Gong et al [22] reported that hyperglycemia induces apoptosis of pancreatic islet endothelial cells. Venieratos et al [23] also showed that high glucose induces apoptosis in mouse pancreatic β-cells. Based upon our result and these reports, we provide the evidence that high glucose-induced stimulation of glutamate is associated with the apoptosis of pancreatic β-cells.
Changes in signal transduction pathways may potentially play an important role in the overall effect of glucose on glutamate uptake. ROS accumulation induces oxidative stress. Increased ROS occurs due to an imbalance of processes that produce ROS and processes that reduce ROS (antioxidant systems) in the pancreas [24]. In the present study, high glucose increased the LPO formation and antioxidants such as NAC and quercetin prevented the high glucose-induced stimulation of glutamate uptake and the decrease of cell viability. Zhang et al [25] also reported a similar result in which high glucose increased oxidative stress and these phenomena lead to β-cell apoptosis. However, they did not examine the role of glutamate. In agreement with our results, Penugonda et al [26] demonstrated that NAC derivative protects the glutamate-induced cytotoxicity in the neuronal cell line. High glucose-induced stimulation of glutamate uptake and stimulation of LPO formation have been reported in many various cells and tissues [27,28]. Nevertheless, there is still no direct evidence demonstrating the relationship between glutamate uptake and LPO formation in pancreatic β-cells. Here, we provide further evidence that high glucose-induced induced increase of LPO formation leads to the stimulation of glutamate uptake, which may be associated with the apoptosis of pancreatic β-cells. There is a possibility that the high glucose-induced stimulation of glutamate uptake triggers the increase of oxidative stress, since L glutamate enhances cell toxicity via the increase of oxidative stress [29]. It is speculated that mechanisms other than oxidative stress could have a role in the glucose-induced stimulation of glutamate uptake. This needs to be elucidated in a further study. In summary, in the HIT-T15 cells, the pancreatic β-cells, oxidative stress appears to mediate the high glucose-induced stimulation of glutamate uptake. In addition, oxidative stress is also involved in mediating the high glucose-induced decrease of cell viability. Therefore, our findings may provide new insights into the pathophysiological mechanisms of glutamate uptake in diabetes mellitus. In conclusion, high glucose induced the stimulation of glutamate uptake and decrease of cell viability via oxidative stress in the pancreatic β-cells.

Acknowledgments

This work was supported by a grant (code #2007040-1034006) from the BioGreen 21 Program of the Rural Development Administration, Korea. This study was supported financially by a research grant from the National Research Foundation (314-2007-1-E00019). This work was also supported by the Grant of the Korean Ministry of Education, Science and Technology (The Regional Core Research Program/Biohousing Research Institute). This work was supported by the Biohousing Research Center.

References

1. Martens GA, Pipeleers D. Glucose, regulator of survival and phenotype of pancreatic beta cells. Vitam Horm. 2009; 80:507–539. PMID: 19251048.
2. Thorens B. Glucose sensing and the pathogenesis of obesity and type 2 diabetes. Int J Obes (Lond). 2008; 32:S62–S71. PMID: 19079282.
crossref
3. Stumvoll M, Goldstein BJ, van Haeften TW. Pathogenesis of type 2 diabetes. Endocr Res. 2007; 32(1-2):19–37. PMID: 18271503.
crossref
4. Spooren W, Lesage A, Lavreysen H, Gasparini F, Steckler T. Metabotropic glutamate receptors: their therapeutic potential in anxiety. Curr Top Behav Neurosci. 2010; 2:391–413. PMID: 21309118.
crossref
5. Yasuo T, Kusuhara Y, Yasumatsu K, Ninomiya Y. Multiple receptor systems for glutamate detection in the taste organ. Biol Pharm Bull. 2008; 31(10):1833–1837. PMID: 18827337.
crossref
6. Morrison JF, Shehab S, Sheen R, Dhanasekaran S, Shaffiullah M, Mensah-Brown E. Sensory and autonomic nerve changes in the monosodium glutamate-treated rat: a model of type II diabetes. Exp Physiol. 2008; 93(2):213–222. PMID: 17911358.
crossref
7. Nawa A, Fujita-Hamabe W, Tokuyama S. Altered intestinal P-glycoprotein expression levels in a monosodium glutamateinduced obese mouse model. Life Sci. 2011; 89(23-24):834–838. PMID: 21983297.
crossref
8. Di Cairano ES, Davalli AM, Perego L, Sala S, Sacchi VF, La Rosa S, Finzi G, Placidi C, Capella C, Conti P, Centonze VE, Casiraghi F, Bertuzzi F, Folli F, Perego C. The glial glutamate transporter 1 (GLT1) is expressed by pancreatic β-cells and prevents glutamate-induced β-cell death. J Biol Chem. 2011; 286(16):14007–14018. PMID: 21335552.
crossref
9. Drews G, Krippeit-Drews P, Dufer M. Oxidative stress and beta-cell dysfunction. Pflugers Arch. 2010; 460(4):703–718. PMID: 20652307.
crossref
10. Stanton RC. Oxidative stress and diabetic kidney disease. Curr Diab Rep. 2011; 11(4):330–336. PMID: 21557044.
crossref
11. Whaley-Connell A, McCullough PA, Sowers JR. The role of oxidative stress in the metabolic syndrome. Rev Cardiovasc Med. 2011; 12(1):21–29. PMID: 21546885.
12. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, Hori M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic β-cells against glucose toxicity. Diabetes. 1999; 48(12):2398–2406. PMID: 10580429.
13. Youl E, Bardy G, Magous R, Cros G, Sejalon F, Virsolvy A, Richard S, Quignard JF, Gross R, Petit P, Bataille D, Oiry C. Quercetin potentiates insulin secretion and protects INS-1 pancreatic β-cells against oxidative damage via the ERK1/2 pathway. Br J Pharmacol. 2010; 161(4):799–814. PMID: 20860660.
crossref
14. Wu F, Orlefors H, Bergström M, Antoni G, Omura H, Eriksson B, Watanabe Y, Långström B. Uptake of 14C- and 11C-labeled glutamate, glutamine and aspartate in vitro and in vivo. Anticancer Res. 2000; 20(1A):251–256. PMID: 10769663.
15. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976; 72:248–254. PMID: 942051.
crossref
16. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem. 1979; 95:351–358. PMID: 36810.
crossref
17. Julio-Pieper M, Flor PJ, Dinan TG, Cryan JF. Exciting times beyond the brain: metabotropic glutamate receptors in peripheral and non-neural tissues. Pharmacol Rev. 2011; 63(1):35–58. PMID: 21228260.
crossref
18. Cline GW, Zhao X, Jakowski AB, Soeller WC, Treadway JL. Islet-selectivity of G-protein coupled receptor ligands evaluated for PET imaging of pancreatic β-cell mass. Biochem Biophys Res Commun. 2011; 412(3):413–418. PMID: 21820405.
crossref
19. Hinoi E, Takarada T, Ueshima T, Tsuchihashi Y, Yoneda Y. Glutamate signaling in peripheral tissues. Eur J Biochem. 2004; 271(1):1–13. PMID: 14686914.
crossref
20. Di Cairano ES, Davalli AM, Perego L, Sala S, Sacchi VF, La Rosa S, Finzi G, Placidi C, Capella C, Conti P, Centonze VE, Casiraghi F, Bertuzzi F, Folli F, Perego C. The glial glutamate transporter 1 (GLT1) is expressed by pancreatic β-cells and prevents glutamate-induced β-cell death. J Biol Chem. 2011; 286(16):14007–14018. PMID: 21335552.
crossref
21. Bai L, Zhang X, Ghishan FK. Characterization of vesicular glutamate transporter in pancreatic alpha- and beta-cells and its regulation by glucose. Am J Physiol Gastrointest Liver Physiol. 2003; 284(5):G808–G814. PMID: 12444014.
22. Gong L, Liu FQ, Wang J, Wang XP, Hou XG, Sun Y, Qin WD, Wei SJ, Zhang Y, Chen L, Zhang MX. Hyperglycemia induces apoptosis of pancreatic islet endothelial cells via reactive nitrogen species-mediated Jun N-terminal kinase activation. Biochim Biophys Acta. 2011; 1813(6):1211–1219. PMID: 21435358.
23. Venieratos PD, Drossopoulou GI, Kapodistria KD, Tsilibary EC, Kitsiou PV. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1â and suppressor of cytokine signalling-1 in mouse pancreatic beta cells. Cell Signal. 2010; 22(5):791–800. PMID: 20067833.
crossref
24. Acharya JD, Ghaskadbi SS. Islets and their antioxidant defense. Islets. 2010; 2(4):225–235. PMID: 21099317.
crossref
25. Zhang Z, Liew CW, Handy DE, Zhang Y, Leopold JA, Hu J, Guo L, Kulkarni RN, Loscalzo J, Stanton RC. High glucose inhibits glucose-6-phosphate dehydrogenase, leading to increased oxidative stress and β-cell apoptosis. FASEB J. 2010; 24(5):1497–1505. PMID: 20032314.
crossref
26. Penugonda S, Mare S, Goldstein G, Banks WA, Ercal N. Effects of N-acetylcysteine amide (NACA), a novel thiol antioxidant against glutamate-induced cytotoxicity in neuronal cell line PC12. Brain Res. 2005; 1056(2):132–138. PMID: 16120436.
27. Lim SK, Han HJ, Kim KY, Park SH. Both B1R and B2R act as intermediate signaling molecules in high glucose-induced stimulation of glutamate uptake in ARPE cells. J Cell Physiol. 2009; 221(3):677–687. PMID: 19725054.
crossref
28. Gaspar JM, Castilho A, Baptista FI, Liberal J, Ambrosio AF. Long-term exposure to high glucose induces changes in the content and distribution of some exocytotic proteins in cultured hippocampal neurons. Neuroscience. 2010; 171(4):981–992. PMID: 20950673.
crossref
29. Amonpatumrat S, Sakurai H, Wiriyasermkul P, Khunweeraphong N, Nagamori S, Tanaka H, Piyachaturawat P, Kanai Y. L-Glutamate enhances methylmercury toxicity by synergistically increasing oxidative stress. J Pharmacol Sci. 2008; 108(3):280–289. PMID: 19023177.
Figure 1
Time and dose response of 25 mM glucose on D-[2,3-3H]-aspartate uptake. (A) Dose dependent effect of glucose and the effect of osmotic load on D-[2,3-3H]-aspartate uptake. Different dosages of glucose (10, 25 or 50 mM glucose), 25 mM mannitol, or 25 mM L-glucose were administered to HITT15 cells. (B) HIT-T15 cells were treated with 25 mM glucose at different time intervals (0-480 min). Then, D-[2,3-3H]-aspartate uptake was determined. Values are mean±SE of three independent experiments performed in triplicate. *P<0.05 vs control (Con: 5 mM glucose).
lar-27-327-g001
Figure 2
Dose response of 25 mM glucose on cell proliferation. Different dosages of glucose (25 or 50 mM glucose), 25 mM mannitol, or 1 mM L-glutamate were administered to HIT-T15 cells for 24 h and cell proliferation was determined using MTT assay. Values are mean±SE of three independent experiments performed in triplicate. *P<0.05 vs control (Control: 5 mM glucose).
lar-27-327-g002
Figure 3
Effect of N-acetyl-L-cysteine (NAC) and quercetin on high glucose-induced lipid peroxide formation (A) and D-[2,3-3H]-aspartate uptake (B). NAC (1 mM) and quercetin (100 µM) were used to treat the HIT-T15 cells for 30 min prior to the treatment of 25 mM glucose for 8 h. Then, lipid peroxides and D-[2,3-3H]-aspartate uptake were conducted. *P<0.05 vs control, **P<0.05 vs 25 mM glucose alone.
lar-27-327-g003
Figure 4
Effect of N-acetyl-L-cysteine (NAC) and quercetin on high glucose-induced cell proliferation. NAC (1 mM) and quercetin (100 µM) were used to treat the HIT-T15 cells for 30 min prior to the treatment of 25 mM glucose for 24 h. Then, cell proliferation was determined using MTT assay. *P<0.05 vs control, **P<0.05 vs 25 mM glucose alone.
lar-27-327-g004
TOOLS
Similar articles